Scientists are increasingly focused on retatrutide, a promising treatment developed by Eli Lilly, as a possible advance in weight reduction . Different than many existing approaches, retatrutide is a double -action compound targeting both GLP-1 and GIP, hormones that influence satiety and blood … Read More